TipRanks
Lexaria releases additional results from Phase 1b study GLP-1-H24-4
📊
AI Sentiment
Positive
6/10
- Home
- LEXX
as of 01-06-2026 4:00pm EST
$0.70
$0.01
-1.24%
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.
| Founded: | 2004 | Country: | Canada |
| Employees: | N/A | City: | KELOWNA |
| Market Cap: | 16.3M | IPO Year: | N/A |
| Target Price: | $1.50 | AVG Volume (30 days): | 1.5M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.66 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.46 - $2.43 | Next Earning Date: | 01-13-2026 |
| Revenue: | $705,923 | Revenue Growth: | 52.05% |
| Revenue Growth (this year): | 13.35% | Revenue Growth (next year): | 78.83% |
AI-Powered LEXX Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 21 hours ago
AI Recommendation
hold
Model Accuracy: 75.33%
75.33%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Lexaria Bioscience Corp. News
LEXX Breaking Stock News: Dive into LEXX Ticker-Specific Updates for Smart Investing
ACCESS Newswire
Lexaria Releases Additional Results from its Successful Phase 1b Study GLP-1-H24-4
📈
AI Sentiment
Highly Positive
8/10
Compare LEXX vs Leading Stocks
See how LEXX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "LEXX Lexaria Bioscience Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.